Home Cart Sign in  
Chemical Structure| 761439-42-3 Chemical Structure| 761439-42-3

Structure of NVP-TAE 684
CAS No.: 761439-42-3

Chemical Structure| 761439-42-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NVP-TAE 684 (TAE 684) is a highly potent and selective ALK inhibitor, blocking the growth of ALCL-derived and ALK-dependent cell lines with IC50 values between 2 and 10 nM.

Synonyms: TAE 684

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NVP-TAE 684

CAS No. :761439-42-3
Formula : C30H40ClN7O3S
M.W : 614.20
SMILES Code : CN1CCN(C2CCN(C3=CC=C(NC4=NC=C(Cl)C(NC5=CC=CC=C5S(=O)(C(C)C)=O)=N4)C(OC)=C3)CC2)CC1
Synonyms :
TAE 684
MDL No. :MFCD11977634
InChI Key :QQWUGDVOUVUTOY-UHFFFAOYSA-N
Pubchem ID :16038120

Safety of NVP-TAE 684

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of NVP-TAE 684

RTK

Isoform Comparison

Biological Activity

Target
  • ALK

    ALK, IC50:3 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
12O12-GICs 0.75 μM 72 h Inhibits ALK receptor and reduces self-renewal capacity of GICs PMC7163450
SH-SY5Y cells 50 nM 1 h Inhibited LPA-induced ERK1/2 phosphorylation and cell proliferation PMC11201523
CLB-GA cell line 300 nM 6 h Inhibition of ALK activity, leading to decreased RET mRNA levels PMC6168456
Caki-1 cells 3nM 1 day Inhibited RRM2 protein expression and reduced cell viability PMC8960981
Kelly cells 50 nM 1 h Inhibited LPA-induced ERK1/2 phosphorylation PMC11201523
H3122 cells 100nM 6 h To evaluate the effect of ALK inhibitor on PI3K signaling PMC3209668
BE(2)C cells 50 nM 1 h Completely suppressed LPA-induced ERK1/2 phosphorylation PMC11201523
NB1 cells 50 nM 1 h Completely suppressed LPA-induced ERK1/2 phosphorylation PMC11201523
LAN-1 cells 50 nM 1 h Inhibited LPA-induced ERK1/2 phosphorylation PMC11201523
SK-N-BE(2)C cell line 300 nM 6 h Inhibition of ALK activity, leading to a slight decrease in RET mRNA levels PMC6168456
CLB-GE cell line 300 nM 6 h Inhibition of ALK activity, leading to decreased RET mRNA levels PMC6168456
CLB-MA cell line 300 nM 6 h Inhibition of ALK activity, leading to decreased RET mRNA levels PMC6168456
HCO1-GICs 0.75 μM 72 h Inhibits ALK receptor and reduces self-renewal capacity of GICs PMC7163450
GH2-GICs 0.75 μM 24 h Inhibits ALK receptor, reduces SOX9 protein levels, and decreases self-renewal capacity of GICs PMC7163450
KB-CV60 cells 0.2 µM and 0.5 µM 72 h To evaluate the reversal effect of NVP-TAE684 on ABCC1-mediated multidrug resistance. Results showed that NVP-TAE684 did not significantly reverse ABCC1-mediated resistance. PMC7056829
HEK293/ABCG2 cells 0.2 µM and 0.5 µM 72 h To evaluate the reversal effect of NVP-TAE684 on ABCG2-transfected cells. Results showed that NVP-TAE684 significantly decreased the resistance in ABCG2-transfected cells. PMC7056829
NCI-H460/MX20 cells 0.2 µM and 0.5 µM 72 h To evaluate the reversal effect of NVP-TAE684 on ABCG2-mediated multidrug resistance. Results showed that NVP-TAE684 significantly decreased the resistance in ABCG2-overexpressing cells. PMC7056829
Neuroblastoma cells (LS cells) 1 μM 24 h Inhibition of ALK activity, reduction of pY-GSK3 expression, affecting cell migration PMC5859133
Neuroblastoma cells (Kelly cells) 1 μM 24 h Inhibition of ALK activity, reduction of pY-GSK3 expression, affecting cell migration PMC5859133

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Cocaine sensitization and conditioned place preference model Oral gavage 10 mg/kg Once daily for 7 days To evaluate the effect of TAE684 on cocaine-induced behavioral responses, results showed TAE684 delayed cocaine sensitization and reduced conditioned place preference PMC3197235
Nude mice H3122 lung cancer xenograft model Orogastric gavage 25 mg/kg/d Once daily for 2 days To evaluate the effect of TAE-684 on tumor growth and PI3K signaling PMC3209668

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.63mL

0.33mL

0.16mL

8.14mL

1.63mL

0.81mL

16.28mL

3.26mL

1.63mL

References

 

Historical Records

Categories